Have a feature idea you'd love to see implemented?
Let us know!
IDXX Idexx Laboratories Inc
Price (delayed)
$412.26
Market cap
$33.76B
P/E Ratio
39.38
Dividend/share
N/A
EPS
$10.47
Enterprise value
$34.43B
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
IDXX's price to earnings (P/E) is 31% lower than its 5-year quarterly average of 57.1 and 22% lower than its last 4 quarters average of 50.6
The company's equity rose by 25% YoY and by 2.4% QoQ
The quick ratio has decreased by 3.6% QoQ
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
81.88M
Market cap
$33.76B
Enterprise value
$34.43B
Price to earnings (P/E)
39.38
Price to book (P/B)
20.97
Price to sales (P/S)
8.83
EV/EBIT
30.57
EV/EBITDA
27.5
EV/Sales
8.95
Revenue
$3.84B
Gross profit
$2.33B
Net income
$866.24M
EBIT
$1.13B
EBITDA
$1.25B
Free cash flow
$792.6M
Per share
Balance sheet
Liquidity
EPS
$10.47
EPS diluted
$10.36
Free cash flow per share
$9.63
Book value per share
$19.66
Revenue per share
$46.71
TBVPS
$34.41
Total assets
$3.35B
Total liabilities
$1.73B
Debt
$977.32M
Equity
$1.62B
Working capital
$424.52M
Debt to equity
0.6
Current ratio
1.42
Quick ratio
0.81
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
32.6%
Gross margin
60.7%
Net margin
22.5%
Operating margin
28.9%
Return on assets
25.9%
Return on equity
55.4%
Return on invested capital
45.5%
Return on capital employed
48.1%
Return on sales
29.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
0.79%
1 week
-4.59%
1 month
-1.52%
1 year
-23.63%
YTD
-25.73%
QTD
-18.4%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.84B
Gross profit
$2.33B
Operating income
$1.11B
Net income
$866.24M
Gross margin
60.7%
Net margin
22.5%
The gross profit has increased by 9% YoY and by 2.1% QoQ
IDXX's revenue is up by 7% year-on-year
The company's net income rose by 5% YoY and by 2.4% QoQ
IDXX's operating margin is down by 4% YoY
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
39.38
P/B
20.97
P/S
8.83
EV/EBIT
30.57
EV/EBITDA
27.5
EV/Sales
8.95
IDXX's price to earnings (P/E) is 31% lower than its 5-year quarterly average of 57.1 and 22% lower than its last 4 quarters average of 50.6
The company's EPS rose by 6% YoY and by 2.7% QoQ
The price to book (P/B) is 68% less than the 5-year quarterly average of 66.1 and 24% less than the last 4 quarters average of 27.7
The company's equity rose by 25% YoY and by 2.4% QoQ
The P/S is 28% below the 5-year quarterly average of 12.3 and 23% below the last 4 quarters average of 11.5
IDXX's revenue is up by 7% year-on-year
Efficiency
How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 35% YoY and by 2.8% QoQ
The return on assets has declined by 9% year-on-year
Idexx Laboratories's return on invested capital has increased by 3.6% YoY and by 2.2% QoQ
The company's return on sales fell by 2.7% YoY
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 93% higher than its total liabilities
The company's total assets rose by 9% YoY
IDXX's total liabilities is down by 6% QoQ and by 3.1% YoY
The debt is 40% less than the equity
IDXX's debt to equity is down by 30% YoY and by 9% QoQ
The company's equity rose by 25% YoY and by 2.4% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.